These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28073423)

  • 1. [Research advances in application of isobaric tags for relative and absolute quantitation in proteomics of hepatocellular carcinoma].
    Qi YZ; Chen LS; Xu P
    Zhonghua Gan Zang Bing Za Zhi; 2016 Dec; 24(12):952-955. PubMed ID: 28073423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteome Differences between Hepatitis B Virus Genotype-B- and Genotype-C-Induced Hepatocellular Carcinoma Revealed by iTRAQ-Based Quantitative Proteomics.
    Wei D; Zeng Y; Xing X; Liu H; Lin M; Han X; Liu X; Liu J
    J Proteome Res; 2016 Feb; 15(2):487-98. PubMed ID: 26709725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC) and Isobaric Tags for Relative and Absolute Quantitation (iTRAQ) Quantitative Proteomic Analysis Identifies Galectin-1 as a Potential Biomarker for Predicting Sorafenib Resistance in Liver Cancer.
    Yeh CC; Hsu CH; Shao YY; Ho WC; Tsai MH; Feng WC; Chow LP
    Mol Cell Proteomics; 2015 Jun; 14(6):1527-45. PubMed ID: 25850433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative proteomics reveals FLNC as a potential progression marker for the development of hepatocellular carcinoma.
    Qi Y; Xu F; Chen L; Li Y; Xu Z; Zhang Y; Wei W; Su N; Zhang T; Fan F; Wang X; Qin X; Zhang L; Liu Y; Xu P
    Oncotarget; 2016 Oct; 7(42):68242-68252. PubMed ID: 27626164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reveal the molecular signatures of hepatocellular carcinoma with different sizes by iTRAQ based quantitative proteomics.
    Wang Y; Liu H; Liang D; Huang Y; Zeng Y; Xing X; Xia J; Lin M; Han X; Liao N; Liu X; Liu J
    J Proteomics; 2017 Jan; 150():230-241. PubMed ID: 27693406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global proteomic profiling in multistep hepatocarcinogenesis and identification of PARP1 as a novel molecular marker in hepatocellular carcinoma.
    Xu X; Liu Z; Wang J; Xie H; Li J; Cao J; Zhou L; Zheng S
    Oncotarget; 2016 Mar; 7(12):13730-41. PubMed ID: 26883192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of label-free and label-based strategies for proteome analysis of hepatoma cell lines.
    Megger DA; Pott LL; Ahrens M; Padden J; Bracht T; Kuhlmann K; Eisenacher M; Meyer HE; Sitek B
    Biochim Biophys Acta; 2014 May; 1844(5):967-76. PubMed ID: 23954498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative proteomics for cancer biomarker discovery.
    Liang S; Xu Z; Xu X; Zhao X; Huang C; Wei Y
    Comb Chem High Throughput Screen; 2012 Mar; 15(3):221-31. PubMed ID: 22221055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current advances in tumor proteomics and candidate biomarkers for hepatic cancer.
    Peng XQ; Wang F; Geng X; Zhang WM
    Expert Rev Proteomics; 2009 Oct; 6(5):551-61. PubMed ID: 19811076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-depth proteomic analysis of tissue interstitial fluid for hepatocellular carcinoma serum biomarker discovery.
    Zhang J; Hao N; Liu W; Lu M; Sun L; Chen N; Wu M; Zhao X; Xing B; Sun W; He F
    Br J Cancer; 2017 Nov; 117(11):1676-1684. PubMed ID: 29024941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Protein Expression Changes in Hepatocellular Carcinoma through iTRAQ.
    Zhang Y; Ying X; Zhao Q; Ma J; Zhang D; He C; Han S
    Dis Markers; 2020; 2020():2632716. PubMed ID: 32076459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of primary hepatocellular carcinoma with single and multiple lesions by iTRAQ-based quantitative proteomics.
    Xing X; Huang Y; Wang S; Chi M; Zeng Y; Chen L; Li L; Zeng J; Lin M; Han X; Liu X; Liu J
    J Proteomics; 2015 Oct; 128():262-71. PubMed ID: 26300425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benchmarking stable isotope labeling based quantitative proteomics.
    Altelaar AF; Frese CK; Preisinger C; Hennrich ML; Schram AW; Timmers HT; Heck AJ; Mohammed S
    J Proteomics; 2013 Aug; 88():14-26. PubMed ID: 23085607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative proteome analysis of HCC cell lines with different metastatic potentials by SILAC.
    Chen N; Sun W; Deng X; Hao Y; Chen X; Xing B; Jia W; Ma J; Wei H; Zhu Y; Qian X; Jiang Y; He F
    Proteomics; 2008 Dec; 8(23-24):5108-18. PubMed ID: 19016532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable isotope labeling by amino acids in cell culture (SILAC) for quantitative proteomics.
    Hoedt E; Zhang G; Neubert TA
    Adv Exp Med Biol; 2014; 806():93-106. PubMed ID: 24952180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers for the early diagnosis of hepatocellular carcinoma.
    Tsuchiya N; Sawada Y; Endo I; Saito K; Uemura Y; Nakatsura T
    World J Gastroenterol; 2015 Oct; 21(37):10573-83. PubMed ID: 26457017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower serum soluble-EGFR is a potential biomarker for metastasis of HCC demonstrated by N-glycoproteomic analysis.
    Hu H; Gao L; Wang C; Li Y; Ma H; Chen L; Qin J; Liu B; Liu Y; Liang C
    Discov Med; 2015 May; 19(106):333-41. PubMed ID: 26105696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative Tissue Proteomics Analysis Reveals Versican as Potential Biomarker for Early-Stage Hepatocellular Carcinoma.
    Naboulsi W; Megger DA; Bracht T; Kohl M; Turewicz M; Eisenacher M; Voss DM; Schlaak JF; Hoffmann AC; Weber F; Baba HA; Meyer HE; Sitek B
    J Proteome Res; 2016 Jan; 15(1):38-47. PubMed ID: 26626371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential proteomic analysis of cancer stem cell properties in hepatocellular carcinomas by isobaric tag labeling and mass spectrometry.
    Ko CH; Cheng CF; Lai CP; Tzu TH; Chiu CW; Lin MW; Wu SY; Sun CY; Tseng HW; Wang CC; Kuo ZK; Wang LM; Chen SF
    J Proteome Res; 2013 Aug; 12(8):3573-85. PubMed ID: 23782096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward the discovery of new biomarkers of hepatocellular carcinoma by proteomics.
    Santamaría E; Muñoz J; Fernández-Irigoyen J; Prìeto J; Corrales FJ
    Liver Int; 2007 Mar; 27(2):163-73. PubMed ID: 17311610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.